CAS: 2007885-39-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
PAT-1251 REF: 3D-HFD88539CAS: 2007885-39-2 | Min. 95% | To inquire | Tue 14 Jan 25 | |
PAT-1251 REF: TM-T12371LCAS: 2007885-39-2 | 99.49% - 99.78% | 113.00 €~3,709.00 € | Tue 21 Jan 25 |
PAT-1251
CAS:2007885-39-2
PAT-1251 is a lysine-based anti-cancer drug that has been shown to be safe and effective …
Formula:
C18H17F4N3O3
Purity:
Min. 95%
Molecular weight:
399.3 g/mol
Ref: 3D-HFD88539
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
PAT-1251
CAS:2007885-39-2
PAT-1251 is an inhibitor of LOXL2 with IC50s of 10, 0.12, and 0.16 μM for …
Formula:
C18H17F4N3O3
Purity:
99.49% - 99.78%
Color and Shape:
Solid
Molecular weight:
399.34
Ref: TM-T12371L
1mg | 113.00 € | ||
5mg | 276.00 € | ||
10mg | 400.00 € | ||
25mg | 627.00 € | ||
50mg | 843.00 € | ||
100mg | 1,090.00 € | ||
200mg | 1,460.00 € | ||
1mL*10mM (DMSO) | 303.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025